Swiss Life International agreed to acquire Elips Life AG from Swiss Re AG (SWX:SREN) on December 10, 2021. The transaction is subject to several closing conditions, including regulatory approval and merger control clearance by the applicable authorities. As of April 5, 2022 Swiss Life secures anti trust approval for the transaction.

The transaction is expected to close in the first half of 2022. As of July 1, 2022, all regulatory approvals and merger control clearances by the applicable authorities have been obtained. ElipsLife is now an integral part of Global Employee Benefits in the division of Swiss Life International